Investor Presentaiton slide image

Investor Presentaiton

Coordinated Specialty Care (CSC) for Early Serious Mental Illness involving First Episode of Psychosis Nevada, 2019-2021 Beginning in 2017, the State selected the evidence-based NAVIGATE Early Treatment Program of Coordinated Specialty Care for First Episode of Psychosis for implementation throughout Nevada. Selection was based on the following factors: The efficacy and feasibility of the NAVIGATE Early Treatment Program for implementation within community mental health settings and in rural and low-density population regions in the United States were demonstrated by clinical trial: Clinical Trials registration: NCT01321177: An Integrated Program for the Treatment of First Episode of Psychosis (RAISE ETP), http://www.clinicaltrials.gov/ct2/show/NCT01321177 The personalized medicine framework of the NAVIGATE Early Treatment Program, which uses targeted therapies from multiple specialties to treat a specific diagnostic category of complex and serious mental illness—the schizophrenia spectrum and other psychotic disorders. The clinical treatment design of the NAVIGATE Early Treatment Program, which is compatible with an outcomes-driven methodology for achieving quality control and continuous performance improvement. For example, medical, psychological and psychosocial assessments are administered continuously (monthly, bi-monthly, quarterly, annually) to evaluate the clinical and functional status of patients, as well as to monitor the efficacy of specialty care interventions and the fidelity of program implementation with the evidence-based protocol. The National NAVIGATE Training Team of experts who were involved in the National Institutes of Health Clinical Trial (RAISE Research Initiative) were available to provide training, guidance and ongoing consultation to states and community-based providers in the implementation of the NAVIGATE Early Treatment Program for First Episode of Psychosis.
View entire presentation